Venetoclax and hypomethylating agents in acute myeloid leukemia: Mayo Clinic series on 86 patientsErika Morsia, Naseema Gangat, Mithun Vinod Shah et al.|American Journal of Hematology|2020Cited by 136
Chronic Myeloid Leukemia, Version 2.2024, NCCN Clinical Practice Guidelines in OncologyNeil P. Shah, Kristina M. Gregory, Ravi Bhatia et al.|Journal of the National Comprehensive Cancer Network|2024Cited by 116
CML and the WHO: Why?Ellin Berman, Brian Druker, Neil P. Shah et al.|Journal of Clinical Oncology|2023Cited by 14
A phase 1 study of the CDK9 inhibitor voruciclib in relapsed/refractory acute myeloid leukemia and B-cell malignanciesMatthew S. Davids, Alexey V. Danilov, Danielle M. Brander et al.|Blood Advances|2024Cited by 9
Validation of the 5th edition of the World Health Organization and International Consensus Classification guidelines for TP53-mutated myeloid neoplasm in an independent international cohortMithun Vinod Shah, Devendra Hiwase, Kevin Hung et al.|Blood Cancer Journal|2025Cited by 6